Translate this page into:
When the usual is unusual – An uncommon presentation of enteric fever
*Corresponding author: Krishnasree Sasikumar, Department of Internal Medicine, Manipal Hospital, Bengaluru, Karnataka, India. krishnasreesasikumar@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Sasikumar K, Havannavar S. When the usual is unusual – An uncommon presentation of enteric fever. Karnataka Med J. 2025;48:14-7. doi: 10.25259/KMJ_60_2024
Abstract
Typhoid fever has an estimated worldwide prevalence of 12–33 million cases with high incidence in India, especially in urban centres. Hemophagocytic lymphohistiocytosis is a rare complication of typhoid fever, which may be fatal if untreated. We describe the case of a young female, with a history of travel from Bali, who presented to our tertiary care centre with high-grade fever, body pain, abdominal pain, loose stools and acute-onset hearing loss. Investigations showed pancytopenia, hyperferritinemia, hypertriglyceridaemia and bone marrow biopsy revealed erythrophagocytic histiocytes and granulomas. Bone marrow culture grew multidrug-resistant Salmonella Typhi. After ruling out other possibilities, including underlying immunodeficiency autoimmune conditions, the diagnosis of secondary HLH was made as per the HLH 2004 diagnostic criteria. The patient responded to culture-sensitive antibiotics, steroids and supportive care. We discuss this case to create awareness about an uncommon complication of a common disease such as typhoid fever.
Keywords
Hemophagocytic lymphohistiocytosis
Salmonella Typhi
Typhoid fever
INTRODUCTION
Enteric fever, caused by Salmonella enterica serovar Typhi and, less commonly, Paratyphi A, B or C, is an acute infectious disease transmitted through the faecal-oral route, primarily through contaminated food or water. It remains a major health issue in regions like India, with an estimated 4.5 million cases annually and a low case fatality rate of 0.2%. Common symptoms include high fever, abdominal pain, headache, gastrointestinal disturbances (constipation or diarrhoea) and general malaise.[1] Without timely antibiotic treatment, serious complications can arise, such as intestinal perforation, gastrointestinal bleeding, hepatitis, cholecystitis, myocarditis, shock, encephalopathy, pneumonia and anaemia. The disease can range from mild febrile illness to life-threatening sepsis and multi-organ failure. Diagnosis is confirmed by blood cultures, and treatment involves antibiotics such as fluoroquinolones, third-generation cephalosporins or azithromycin. Preventive measures include improved sanitation, vaccination and safe food and water practices. We report a case of a previously healthy female with a history of travel from Bali with typhoid fever complicated by sepsis, conductive hearing loss and a rare complication, hemophagocytic lymphohistiocytosis (HLH).
CASE REPORT
This case involves a 24-year-old female with a history of hypothyroidism, with recent travel history to Bali, who presented with high-grade fever of 12-day duration associated with headache, myalgia, dizziness and loose stools with occasional blood in stools, along with abdominal pain and multiple oral ulcers. Her fever persisted despite initial treatment with antibiotics (augmentin and ceftriaxone). She also developed acute-onset bilateral conductive hearing loss. On examination, she was febrile had pallor, and multiple oral ulcers, but no signs of jaundice, cyanosis or oedema with a heart rate of 145 bpm, blood pressure 110/70 mmHg and oxygen saturation of 99%. There were no significant findings on cardiovascular or respiratory examination, and abdominal examination was soft and non-tender. Investigations revealed a falling haemoglobin (from 11.1 g/ dL to 6.0 g/dL), declining platelet count and total count and elevated liver enzymes, with high procalcitonin levels (11.78), suggesting an infectious cause. Stool and blood cultures as well as tests for common tropical infections such as dengue, typhoid, malaria, rickettsial fever, scrub typhus, brucella and leptospirosis and immunoglobulin-M, hepatitis A virus, hepatitis E virus, cytomegalovirus, herpes simplex virus were negative. However, imaging (contrast-enhanced computed tomography abdomen) showed mild hepatosplenomegaly, mucosal thickening in the terminal ileum and mesenteric lymphadenopathy, which raised concern for an infective or inflammatory aetiology.
Further workup included a colonoscopy, which revealed active ileocolitis with ulcers in the terminal ileum, caecum and ascending colon, suggestive of an infective origin, likely salmonella. Keeping a possibility of HLH, serum ferritin and triglycerides were sent. Her serum ferritin was significantly elevated and her triglyceride was elevated with low fibrinogen. She had fever, hepatosplenomegaly, pancytopenia, elevated ferritin and elevated triglycerides which satisfied HLH 2004 criteria. Bone marrow aspiration with biopsy showed hypocellular marrow with erythrophagocytic histiocytes (hemophagocytosis) confirming HLH along with hyperferretinemia, hypofibrinogenaemia and hypertriglyceridaemia with cytopenias and hepatosplenomegaly [Figure 1 and Figure 2a-b]. Bone marrow culture was positive for multidrug-resistant Salmonella Typhi, confirming the diagnosis. The patient was started on IV azithromycin and amikacin, and given the possible HLH, corticosteroid therapy (dexamethasone) was initiated. Her clinical condition improved rapidly, with resolution of fever, normalisation of blood counts and improvement in hearing.

- Bone marrow biopsy showing hemophagocytosis of lymphocyte (yellow arrow). Stain: Romanowsky stain, Magnification: 200x.

- (a and b) Bone marrow biopsy showing hemophagocytosis of lymphocyte and neutrophil (yellow arrows). Stain: Romanowsky stain, Magnification: 200x.
Histopathological examination of the colon biopsies confirmed active ileocolitis with features suggestive of Salmonella infection. The patient was transfused with two units of packed red blood cells to manage her anaemia. Over the course of treatment, her inflammatory markers improved, and she became afebrile and haemodynamically stable. She was discharged with follow-up instructions for continued monitoring of blood counts, liver function and further surveillance for potential complications, including hearing recovery and monitoring for HLH.
This case underscores the importance of a thorough diagnostic approach in the evaluation of fever of unknown origin with pancytopenia and multisystem involvement, leading to the identification of Salmonella-induced ileocolitis and HLH, which required prompt antibiotic and corticosteroid treatment for recovery. This case also emphasises the difficulty in diagnosing a fever of unknown origin already treated with multiple antibiotics, where cultures will come negative and the final diagnosis was made from bone marrow culture and also the uncommon presentation of a very common disease.
DISCUSSION
Typhoid fever, caused by Salmonella enterica serotype Typhi and, less commonly, S. Paratyphi A, B and C, is a systemic infectious disease transmitted primarily through the ingestion of contaminated food or water. The clinical spectrum of typhoid fever ranges from mild febrile illness to severe toxemia with multi-organ involvement. Approximately 10–15% of patients may develop severe disease, often complicated by gastrointestinal bleeding, intestinal perforation or typhoid encephalopathy.
Typhoid encephalopathy, manifesting as confusion, insomnia and dizziness, occurs in 3–10% of cases and is associated with increased mortality. Other rare but reported complications include hepatic and splenic granulomas, liver abscesses, pleural effusion, multiple organ dysfunction syndrome, hemophagocytic syndrome (HPS), haemolytic uraemic syndrome, glomerulonephritis and pericarditis. Early recognition of such complications is critical, as timely and appropriate interventions can significantly reduce morbidity and mortality.[2]
HPS in typhoid fever
HPS, also known as HLH, is a rare but potentially life-threatening complication that may develop secondary to typhoid fever. HLH results from excessive and uncontrolled activation of T-cells and histiocytes, leading to a hyperinflammatory state characterised by excessive cytokine release and hemophagocytosis. Clinically, HLH presents with prolonged fever, hepatosplenomegaly, cytopenias, liver dysfunction and markedly elevated serum ferritin levels.[3]
HLH is broadly classified into two types: Primary (familial, genetic forms) and secondary HLH, which is triggered by infections, malignancies or autoimmune disorders. Infection-associated HLH (IAH) is most commonly precipitated by viral infections, particularly Epstein–Barr virus, though bacterial, parasitic and fungal infections are also recognised triggers.
The diagnosis of HLH is based on the HLH-2004 criteria proposed by the Histiocyte Society, which includes a combination of clinical and laboratory features. These criteria encompass persistent fever, splenomegaly, cytopenias affecting ≥2 cell lines, hypertriglyceridaemia, hypofibrinogenaemia, hyperferritinemia, elevated transaminases and LDH and demonstration of hemophagocytosis in bone marrow or other tissues. Additional markers such as elevated soluble interleukin-2 receptor alpha (sCD25) levels and reduced natural killer cell activity can aid in diagnosis. However, these findings are non-specific and may overlap with conditions such as sepsis, malignancy or systemic inflammatory response syndrome, making early recognition and diagnosis particularly challenging.[4]
Management of IAH
The cornerstone of treatment in IAH is prompt initiation of therapy targeting both the underlying infection and the dysregulated immune response. In many cases, HLH secondary to bacterial infections such as typhoid may respond to antibiotics and supportive care alone, with improvement seen in 60–70% of cases. However, in patients with severe or persistent symptoms, especially with progressive cytopenias or organ dysfunction, immunosuppressive therapy becomes necessary.[5]
Corticosteroids, particularly dexamethasone, are often employed to modulate the excessive immune activation. In this patient, clinical deterioration despite antibiotic therapy and supportive measures necessitated the initiation of dexamethasone. The therapeutic response was evident with subsequent clinical improvement and resolution of bicytopenia, reinforcing the diagnosis of HLH.
This case underscores the importance of maintaining a high index of suspicion for HLH in patients with complicated infections, particularly those presenting with unexplained cytopenias or systemic inflammation. Early recognition and timely initiation of immunosuppressive therapy are crucial to improving outcomes and preventing progression to irreversible organ damage or death.[6]
CONCLUSION
The occurrence of HPS (HLH) in patients with complicated typhoid fever is a rare but critical consideration. Given the potential for rapid deterioration, timely recognition and the initiation of appropriate treatment, including immunosuppressive therapy, are vital. Clinicians should maintain a high index of suspicion for HLH in patients with complicated infections and cytopenias, and a multidisciplinary approach is essential for optimising outcomes in these critically ill patients.
Authors’ contributions:
KS, SH: Case workup investigations data gathering compiling drafting and editing manuscript
Ethical approval:
Institutional Review Board approval is not required.
Declaration of patient consent:
The authors certify that they have obtained all appropriate patient consent.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- Secondary hemophagocytic lymphohistiocytosis due to typhoid fever. Cureus. 2023;15:e42175.
- [CrossRef] [Google Scholar]
- HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124-31.
- [CrossRef] [PubMed] [Google Scholar]
- Enteric fever-associated hemophagocytic lymphohistiocytosis: A systematic review of clinical characteristics and outcomes. Am J Trop Med Hyg. 2024;110:1217-22.
- [CrossRef] [PubMed] [Google Scholar]
- Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. J Microbiol Immunol Infect. 2011;44:191-7.
- [CrossRef] [PubMed] [Google Scholar]
- [Hemophagocytic lymphohistiocytosis-a contemporary medical problem] Pol Merkur Lekarski. 2012;32:59-63.
- [Google Scholar]
